Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Launches Certified Service Program for MassArray

NEW YORK (GenomeWeb News) – Sequenom today said that it has launched a certified service program for its MassArray System and has named the first laboratory participants.

The San Diego-based firm said that certifications have been awarded to McGill University and Genome Quebec Innovation Centre in Montreal; Knight Diagnostic Laboratories at Oregon Health & Science University; GeneWorks in Adelaide, Australia; The Clinical Genomics Centre in Toronto; Karolinska University Hospital in Sweden; NewGene in Newcastle, UK; DNA LandMarks, which is a plant and animal genomics subsidiary of BASF and is based in Quebec; and several unnamed labs based in Asia.

Participants in the CSP are certified for offering research services on the MassArray System, a MALDI-TOF-based mass spectrometry system for a variety of genomic analysis applications.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.